Showing results (131-140 of 587) with videos related to
Sort By:
Pageof 59
Cancer Research|May 14, 2013
Inhibition of tumor cell migration by LD22-4, an N-terminal fragment of 24-kDa FGF2, is mediated by Neuropilin 1Ling Zhang, Graham C Parry, Eugene G LevinChemotherapy|October 29, 2000
Indomethacin inhibits the accumulation of tumor cells in mouse lungs and subsequent growth of lung metastasesG Levin, N Kariv, E Khomiak, et al.Bulletin of the World Health Organization|January 1, 1975
Hepatitis B antigen, antigen subtypes, and hepatitis B antibody in normal subjects and patients with liver diseaseK Nishioka, A G Levin, M J SimonsHypertension (Dallas, Tex. : 1979)|February 1, 1988
Total plasma dopamine/norepinephrine ratio in catecholamine-secreting tumors. Its relation to hypertensionA Puyo, G Levin, I Armando, et al.La Revue De Medecine Interne|May 1, 1987
[Value of a LHRH agonist (Zoladex) in hormonotherapy of advanced cancers of the prostate. Apropos of 22 patients]N Bourgne, B Audhuy, F Kohser, et al.Journal of Cell Science|January 1, 1997
The expression of endothelial tissue plasminogen activator in vivo: a function defined by vessel size and anatomic locationE G Levin, L Santell, K G OsbornGeneral Pharmacology|March 1, 1993
The involvement of sodium ions in the positive inotropic effect of naloxoneG Levin, M Gafni, N Roz, et al.Brain Research|January 8, 1999
Targeting of tissue plasminogen activator into the regulated secretory pathway of neuroendocrine cellsL Santell, K R Marotti, E G LevinTrends in Biochemical Sciences|October 3, 1998
Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replicationA Rein, L E Henderson, J G LevinBlood|August 15, 1992
Stimulation of tissue plasminogen activator production by retinoic acid: synergistic effect on protein kinase C-mediated activationR D Medh, L Santell, E G LevinPageof 59